comparemela.com

Latest Breaking News On - Nick galakatos - Page 1 : comparemela.com

Private Equity Acquires A Taste For Drug Development

Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in the sector, raising dedicated funds and coming up with deals that compensate

Nick galakatosTom davidsonBlackstone incAlnylam pharmaceuticals incApollo global management incPartners incPfizer incAutolus therapeutics plcOpthea ltdLife sciences partnersBio pharma incCo incCarlyle group incEvaluate pharmaSofinnova partnersBridgebio pharma inc

Private equity acquires a taste for drug development

By David Carnevali (Reuters) - Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in .

New yorkUnited statesNick galakatosTom davidsonDavid carnevaliGreg roumeliotisBlackstone incAlnylam pharmaceuticals incApollo global management incPartners incPfizer incAutolus therapeutics plcOpthea ltdLife sciences partnersBio pharma incCo inc

Investing in Europe s future – POLITICO

Helping to move ideas from inception to reality, private investment will be key to solving the world’s most pressing issues.

United statesUnited kingdomCity ofThe netherlandsElizabeth lewisNick galakatosJames seppalaFarhad karimGemma katakyOffice groupSage homesLeaf livingSage homeAinscough crane hireClimate changeEnergy efficiency

How a New York private equity giant became Boston s biggest commercial landlord — and biotech investor

How a New York private equity giant became Boston’s biggest commercial landlord and biotech investor Jon Chesto © David L. Ryan/Globe Staff Blackstone recently put local executive Nick Galakatos, who runs Blackstone Life Sciences out of Cambridge, on BioMed’s board of directors. The biggest private-equity firm in the world has been pouring money into Boston by the billions, buying up prime real estate and investing in promising biotechs. Blackstone Group said it now owns more than $12 billion worth of real estate in the area, making it the largest commercial landlord in the region by its own estimate. The New York-based firm also has chosen Cambridge as home for its $4.6 billion life sciences investment fund, the biggest of its kind.

United statesSan diegoUnited kingdomAl iskandariyahAlan goldKendall squareDavidl ryanNick galakatosTim schoenJon grayRobert coughlinKathleen mccarthyJohn maraganoreJohn hancockBiomed realtyBoston properties

vimarsana © 2020. All Rights Reserved.